Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Rachel Vatnsdal is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/06/2025 | NVST | Buy Now | Envista Holdings | $16.90 | 12.43% | Rachel Vatnsdal59% | $20 → $19 | Maintains | Neutral | Get Alert |
| 03/06/2025 | WAT | Buy Now | Waters | $382.15 | 2.05% | Rachel Vatnsdal59% | $380 → $390 | Maintains | Neutral | Get Alert |
| 02/25/2025 | TEM | Buy Now | Tempus AI | $45.86 | 19.93% | Rachel Vatnsdal59% | $50 → $55 | Downgrade | Overweight → Neutral | Get Alert |
| 02/21/2025 | RGEN | Buy Now | Repligen | $145.50 | 37.46% | Rachel Vatnsdal59% | $190 → $200 | Maintains | Overweight | Get Alert |
| 02/21/2025 | GH | Buy Now | Guardant Health | $44.27 | 24.24% | Rachel Vatnsdal59% | $50 → $55 | Maintains | Overweight | Get Alert |
| 02/13/2025 | TXG | Buy Now | 10x Genomics | $10.47 | 14.61% | Rachel Vatnsdal59% | $14 → $12 | Maintains | Neutral | Get Alert |
| 02/04/2025 | TWST | Buy Now | Twist Bioscience | $42.59 | -6.08% | Rachel Vatnsdal59% | $35 → $40 | Maintains | Underweight | Get Alert |
| 11/26/2024 | A | Buy Now | Agilent Technologies | $123.10 | 29.98% | Rachel Vatnsdal59% | $165 → $160 | Maintains | Overweight | Get Alert |
| 11/04/2024 | WAT | Buy Now | Waters | $382.15 | -0.56% | Rachel Vatnsdal59% | $340 → $380 | Maintains | Neutral | Get Alert |
| 10/30/2024 | TXG | Buy Now | 10x Genomics | $10.47 | 33.72% | Rachel Vatnsdal59% | $20 → $14 | Maintains | Neutral | Get Alert |
| 09/20/2024 | TMO | Buy Now | Thermo Fisher Scientific | $521.50 | 28.48% | Rachel Vatnsdal59% | $650 → $670 | Maintains | Overweight | Get Alert |
| 08/12/2024 | HSIC | Buy Now | Henry Schein | $72.00 | 11.11% | Rachel Vatnsdal59% | $88 → $80 | Maintains | Overweight | Get Alert |
| 08/08/2024 | NVST | Buy Now | Envista Holdings | $16.90 | -5.33% | Rachel Vatnsdal59% | $23 → $16 | Downgrade | Overweight → Neutral | Get Alert |
| 08/07/2024 | TEM | Buy Now | Tempus AI | $45.86 | 2.49% | Rachel Vatnsdal59% | $42 → $47 | Maintains | Overweight | Get Alert |
| 08/07/2024 | MYGN | Buy Now | Myriad Genetics | $9.90 | 102.02% | Rachel Vatnsdal59% | $17 → $20 | Maintains | Underweight | Get Alert |
| 08/06/2024 | AKYA | Buy Now | Akoya Biosciences | $1.56 | — | Rachel Vatnsdal59% | — | Downgrade | Overweight → Neutral | Get Alert |
| 08/05/2024 | MTD | Buy Now | Mettler-Toledo Intl | $1.23K | 13.82% | Rachel Vatnsdal59% | $1300 → $1400 | Maintains | Neutral | Get Alert |
| 08/02/2024 | ADPT | Buy Now | Adaptive Biotechnologies | $7.35 | -18.37% | Rachel Vatnsdal59% | $5 → $6 | Maintains | Overweight | Get Alert |
| 07/31/2024 | RGEN | Buy Now | Repligen | $145.50 | 37.46% | Rachel Vatnsdal59% | $190 → $200 | Maintains | Overweight | Get Alert |
| 07/30/2024 | RVTY | Buy Now | Revvity | $112.70 | 6.48% | Rachel Vatnsdal59% | $105 → $120 | Maintains | Neutral | Get Alert |
| 07/18/2024 | TXG | Buy Now | 10x Genomics | $10.47 | 91.02% | Rachel Vatnsdal59% | $40 → $20 | Downgrade | Overweight → Neutral | Get Alert |
| 07/09/2024 | TEM | Buy Now | Tempus AI | $45.86 | -8.42% | Rachel Vatnsdal59% | → $42 | Initiates | → Overweight | Get Alert |
| 05/30/2024 | A | Buy Now | Agilent Technologies | $123.10 | 25.91% | Rachel Vatnsdal59% | $165 → $155 | Maintains | Overweight | Get Alert |
| 05/08/2024 | ADPT | Buy Now | Adaptive Biotechnologies | $7.35 | -31.97% | Rachel Vatnsdal59% | $8 → $5 | Maintains | Overweight | Get Alert |
| 05/02/2024 | RGEN | Buy Now | Repligen | $145.50 | 37.46% | Rachel Vatnsdal59% | $230 → $200 | Maintains | Overweight | Get Alert |
| 05/02/2024 | NVST | Buy Now | Envista Holdings | $16.90 | 36.09% | Rachel Vatnsdal59% | $29 → $23 | Maintains | Overweight | Get Alert |
| 04/25/2024 | TMO | Buy Now | Thermo Fisher Scientific | $521.50 | 24.64% | Rachel Vatnsdal59% | $600 → $650 | Maintains | Overweight | Get Alert |
| 04/22/2024 | PACB | Buy Now | Pacific Biosciences | $1.22 | — | Rachel Vatnsdal59% | — | Downgrade | Overweight → Neutral | Get Alert |
| 03/06/2024 | AKYA | Buy Now | Akoya Biosciences | $1.56 | 541.03% | Rachel Vatnsdal59% | $12 → $10 | Maintains | Overweight | Get Alert |
| 03/06/2024 | HSIC | Buy Now | Henry Schein | $72.00 | 22.22% | Rachel Vatnsdal59% | $82 → $88 | Maintains | Overweight | Get Alert |
| 02/15/2024 | ADPT | Buy Now | Adaptive Biotechnologies | $7.35 | 8.84% | Rachel Vatnsdal59% | $11 → $8 | Maintains | Overweight | Get Alert |
| 02/14/2024 | BRKR | Buy Now | Bruker | $47.14 | 90.92% | Rachel Vatnsdal59% | $60 → $90 | Upgrade | Neutral → Overweight | Get Alert |
| 12/20/2023 | RGEN | Buy Now | Repligen | $145.50 | 44.33% | Rachel Vatnsdal59% | $170 → $210 | Maintains | Overweight | Get Alert |
| 12/20/2023 | A | Buy Now | Agilent Technologies | $123.10 | 34.04% | Rachel Vatnsdal59% | $140 → $165 | Maintains | Overweight | Get Alert |
| 12/20/2023 | DHR | Buy Now | Danaher | $213.00 | 26.76% | Rachel Vatnsdal59% | $250 → $270 | Maintains | Overweight | Get Alert |
| 12/12/2023 | HSIC | Buy Now | Henry Schein | $72.00 | 13.89% | Rachel Vatnsdal59% | $71 → $82 | Upgrade | Neutral → Overweight | Get Alert |
| 11/27/2023 | NSTG | Buy Now | NanoString Technologies | — | — | Rachel Vatnsdal59% | — | Downgrade | Overweight → Neutral | Get Alert |
| 11/21/2023 | A | Buy Now | Agilent Technologies | $123.10 | 13.73% | Rachel Vatnsdal59% | $150 → $140 | Maintains | Overweight | Get Alert |
| 11/10/2023 | ADPT | Buy Now | Adaptive Biotechnologies | $7.35 | 49.66% | Rachel Vatnsdal59% | $12 → $11 | Maintains | Overweight | Get Alert |
| 11/08/2023 | WAT | Buy Now | Waters | $382.15 | -34.58% | Rachel Vatnsdal59% | $260 → $250 | Maintains | Neutral | Get Alert |
| 11/07/2023 | MYGN | Buy Now | Myriad Genetics | $9.90 | 41.41% | Rachel Vatnsdal59% | $17 → $14 | Maintains | Underweight | Get Alert |
| 11/02/2023 | NVST | Buy Now | Envista Holdings | $16.90 | 89.35% | Rachel Vatnsdal59% | $42 → $32 | Maintains | Overweight | Get Alert |
| 10/25/2023 | DHR | Buy Now | Danaher | $213.00 | 17.37% | Rachel Vatnsdal59% | $260 → $250 | Maintains | Overweight | Get Alert |
| 10/17/2023 | WAT | Buy Now | Waters | $382.15 | -31.96% | Rachel Vatnsdal59% | $290 → $260 | Maintains | Neutral | Get Alert |
| 10/17/2023 | TMO | Buy Now | Thermo Fisher Scientific | $521.50 | 20.81% | Rachel Vatnsdal59% | $670 → $630 | Maintains | Overweight | Get Alert |
| 10/17/2023 | RGEN | Buy Now | Repligen | $145.50 | 23.71% | Rachel Vatnsdal59% | $200 → $180 | Maintains | Overweight | Get Alert |
| 10/17/2023 | MTD | Buy Now | Mettler-Toledo Intl | $1.23K | -10.57% | Rachel Vatnsdal59% | $1300 → $1100 | Maintains | Neutral | Get Alert |
| 10/17/2023 | BRKR | Buy Now | Bruker | $47.14 | 37.89% | Rachel Vatnsdal59% | $70 → $65 | Maintains | Neutral | Get Alert |
| 10/17/2023 | RVTY | Buy Now | Revvity | $112.70 | -2.4% | Rachel Vatnsdal59% | $130 → $110 | Maintains | Neutral | Get Alert |
| 10/17/2023 | DHR | Buy Now | Danaher | $213.00 | 22.07% | Rachel Vatnsdal59% | $300 → $260 | Maintains | Overweight | Get Alert |
| 08/16/2023 | A | Buy Now | Agilent Technologies | $123.10 | 21.85% | Rachel Vatnsdal59% | $155 → $150 | Maintains | Overweight | Get Alert |
| 08/07/2023 | MYGN | Buy Now | Myriad Genetics | $9.90 | 71.72% | Rachel Vatnsdal59% | $18 → $17 | Maintains | Underweight | Get Alert |
| 08/02/2023 | RVTY | Buy Now | Revvity | $112.70 | 15.35% | Rachel Vatnsdal59% | $120 → $130 | Maintains | Neutral | Get Alert |
| 07/27/2023 | TMO | Buy Now | Thermo Fisher Scientific | $521.50 | 28.48% | Rachel Vatnsdal59% | $660 → $670 | Maintains | Overweight | Get Alert |
| 05/25/2023 | TMO | Buy Now | Thermo Fisher Scientific | $521.50 | 26.56% | Rachel Vatnsdal59% | $675 → $660 | Maintains | Overweight | Get Alert |
| 05/24/2023 | A | Buy Now | Agilent Technologies | $123.10 | 25.91% | Rachel Vatnsdal59% | $170 → $155 | Maintains | Overweight | Get Alert |
| 05/22/2023 | CTLT | Buy Now | Catalent | — | — | Rachel Vatnsdal59% | $90 → $45 | Downgrade | Overweight → Neutral | Get Alert |
| 02/02/2023 | TMO | Buy Now | Thermo Fisher Scientific | $521.50 | 29.43% | Rachel Vatnsdal59% | $650 → $675 | Maintains | Overweight | Get Alert |
| 11/10/2022 | AMRS | Buy Now | Amyris | — | — | Rachel Vatnsdal59% | — | Downgrade | Neutral → Underweight | Get Alert |
| 10/27/2022 | TMO | Buy Now | Thermo Fisher Scientific | $521.50 | 24.64% | Rachel Vatnsdal59% | $715 → $650 | Maintains | Overweight | Get Alert |
| 10/21/2022 | DHR | Buy Now | Danaher | $213.00 | 47.89% | Rachel Vatnsdal59% | $350 → $315 | Maintains | Overweight | Get Alert |
| 07/29/2022 | TMO | Buy Now | Thermo Fisher Scientific | $521.50 | 37.1% | Rachel Vatnsdal59% | $700 → $715 | Maintains | Overweight | Get Alert |
| 06/24/2022 | AMRS | Buy Now | Amyris | — | — | Rachel Vatnsdal59% | — | Initiates | → Neutral | Get Alert |
